Progestin Resistance
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia (NCT07714070) | Peking University People's Hospital | 2026-07-01 |
Track Progestin Resistance automatically
Every clearance here is in the API, with alerts when new ones post.